Federal contractor · NIWOT, CO
VESICLE THERAPEUTICS INC
No contract obligations recorded for VESICLE THERAPEUTICS INC in FY2026. Since FY2022: $475.2K.
- Obligations · FY2026
- $0
- New awards
- 0
- Sole-source
- —
- Single offer
- —
- UEI
- KALZFKXVQTA6
Spending by fiscal year
Obligations per federal fiscal year (October–September).
- 475.2KFY2022
- 0FY2023
- 0FY2024
Top buying agencies
Obligations in FY2026.
No contract obligations recorded for VESICLE THERAPEUTICS INC in FY2026.
What was bought · Where the work was performed
Obligations in FY2026.
What was bought
Where the work was performed
Integrity signals
Shares of the year's obligations, next to the country's.
Federal grants & assistance received
Grants, loans (counted at their subsidy cost), direct payments and insurance, by fiscal year of the action (USAspending.gov, FABS). Reported apart from contracts and never added to them.
VESICLE THERAPEUTICS INC received $0 in federal assistance in FY2026, on 1 actions (0 new awards), −100% vs FY2025.
- Assistance · FY2026
- $0
- New awards
- 0
- Actions
- 1
- Since FY2022
- $1.1M
Assistance by fiscal year
- 744.7KFY2022
- 0FY2024
- 400KFY2025
- 0FY2026
Largest awards
- 93.395 · Cancer Treatment Research· National Institutes of Health· Project grant· Sep 15, 2025 – Jul 16, 2026· R41CA287794
Source: Federal financial assistance transactions (Financial Assistance Broker Submission) (U.S. Department of the Treasury, USAspending.gov), data current to Oct 10, 2026, loaded Oct 10, 2026 · FY2022–FY2026.
Source: Federal contract transactions (Federal Procurement Data System) (U.S. Department of the Treasury, USAspending.gov), data current to Oct 10, 2026, loaded Oct 10, 2026.